Through the combination treatment of breast cancer using MANS peptide and paclitaxel, we confirmed that MANS peptide has an inhibitory effect on paclitaxel-enhanced MARCKS phosphorylation, as PKC inhibitor did (Figure 4A). The gene discussed is PRRT2; the disease is breast cancer.